Allogene Therapeutics, Inc. - COM (ALLO)

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Equity / COM
Number of holders
158
Total Shares
83.1M
Shares change
-3.76M
Total reported value, excl. options
$3.13B
Value change
-$164M
Put/Call ratio
0.97
Number of buys
78
Number of sells
-92
Price
$37.71
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.